(RoyalPatriot.com )- The Johnson & Johnson COVID-19 vaccine is back in circulation after being put on pause for a while. However, there may be new trouble brewing for this vaccine.
On Wednesday, officials with the Centers for Disease Control and Prevention said they have identified 28 cases of people having blood clots with low platelets after receiving the company’s vaccine.
Those 28 cases were found by the CDC out of more than 8.7 million doses of the vaccine have been administered throughout the country thus far. The Johnson & Johnson vaccine is administered in a single dose, rather than as two separate doses like the Pfizer-BioNTech and Moderna vaccines are.
There have been no blood clot cases reported from either of the Pfizer-BioNTech or Moderna vaccines. Those vaccines both are classified as mRNA vaccines, which are much different than many other vaccines that have been produced.
Of the 28 people who suffered blood clots with low platelets after taking the Johnson & Johnson vaccine, four of them were still hospitalized as of May 7. One of those people is still in the Intensive Care Unit, and two were discharged to a post-acute care facility.
Last month, the distribution and administration of the Johnson & Johnson vaccine was put on hold for 10 days. That allowed various health agencies to investigate the blood clots, which while rare, could prove to be potentially fatal.
That pause time also gave medical providers information and education on how they should treat the side effect if it popped up.
Twelve of the patients who suffered the blood clots were treated with herapin. That drug is a blood thinner that’s normally used for blood clots. However, it’s actually made the blood clot condition in the Johnson & Johnson cases much worse.
On April 23, the Johnson & Johnson vaccine was given the green light to resume administration. At that time, the CDC identified only 15 cases of the blood clots, while there were 8 million shots given.
That caused some concern when the CDC made the announcement of 28 cases this week, because many thought it meant they are still happening. However, the CDC clarified that all 28 of these blood clot cases happened before the Johnson & Johnson vaccine was paused back on April 13.
The patients who have suffered the blood clots from this specific vaccine had a median age of 40. Their total ages ranged anywhere from 18 to 59. Most of the cases (22 in all) happened with women. Only six of the cases happened with men.
The condition is officially called thrombosis with thrombocytopenia syndrome. The CDC said the symptoms of it appear to be similar to the side effects that are being observed in Europe with AstraZeneca’s COVID-19 vaccine. That company’s vaccine has not been approved for use in the United States.
Despite these 28 confirmed cases of blood clots, the CDC continues to say that the potential benefits of the Johnson & Johnson vaccine that are known are much greater than the potential risks with taking it.
It wouldn’t be a surprise, though, if people who wanted to get the vaccine would prefer not to get Johnson & Johnson’s version.